NO851172L - Fremgangsmaate og innretning for fremstilling av varierende konsentrasjonsmoenstre av kjemisk eller biologisk aktive stoff - Google Patents
Fremgangsmaate og innretning for fremstilling av varierende konsentrasjonsmoenstre av kjemisk eller biologisk aktive stoffInfo
- Publication number
- NO851172L NO851172L NO851172A NO851172A NO851172L NO 851172 L NO851172 L NO 851172L NO 851172 A NO851172 A NO 851172A NO 851172 A NO851172 A NO 851172A NO 851172 L NO851172 L NO 851172L
- Authority
- NO
- Norway
- Prior art keywords
- concentration
- substance
- decreases
- carrier
- rectangular area
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims abstract description 91
- 238000000034 method Methods 0.000 title claims abstract description 30
- 239000013543 active substance Substances 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title claims 3
- 230000007423 decrease Effects 0.000 claims description 22
- 244000005700 microbiome Species 0.000 claims description 21
- 108090000790 Enzymes Proteins 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 16
- 239000000427 antigen Substances 0.000 claims description 13
- 108091007433 antigens Proteins 0.000 claims description 13
- 102000036639 antigens Human genes 0.000 claims description 13
- 239000002609 medium Substances 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 238000009792 diffusion process Methods 0.000 claims description 10
- 239000013558 reference substance Substances 0.000 claims description 10
- 239000001963 growth medium Substances 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 9
- 239000012620 biological material Substances 0.000 claims description 5
- 229940088623 biologically active substance Drugs 0.000 claims 1
- 239000012876 carrier material Substances 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 238000004445 quantitative analysis Methods 0.000 claims 1
- 239000012429 reaction media Substances 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 11
- 230000000845 anti-microbial effect Effects 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 230000003505 mutagenic effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000000951 immunodiffusion Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 229910002651 NO3 Inorganic materials 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 231100000518 lethal Toxicity 0.000 description 3
- 230000001665 lethal effect Effects 0.000 description 3
- 231100000243 mutagenic effect Toxicity 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- 206010028400 Mutagenic effect Diseases 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000315 carcinogenic Toxicity 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000013048 microbiological method Methods 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- UMFJAHHVKNCGLG-UHFFFAOYSA-N n-Nitrosodimethylamine Chemical compound CN(C)N=O UMFJAHHVKNCGLG-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000002132 β-lactam antibiotic Substances 0.000 description 2
- 229940124586 β-lactam antibiotics Drugs 0.000 description 2
- PJDINCOFOROBQW-LURJTMIESA-N (3S)-3,7-diaminoheptanoic acid Chemical compound NCCCC[C@H](N)CC(O)=O PJDINCOFOROBQW-LURJTMIESA-N 0.000 description 1
- 241000186046 Actinomyces Species 0.000 description 1
- 229930183010 Amphotericin Natural products 0.000 description 1
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
- 108010062877 Bacteriocins Proteins 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 108020004256 Beta-lactamase Proteins 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 108010073254 Colicins Proteins 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108090000913 Nitrate Reductases Proteins 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 108010040201 Polymyxins Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229940074608 allergen extract Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- -1 aminoglycosides Substances 0.000 description 1
- 229940009444 amphotericin Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229940045799 anthracyclines and related substance Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000009635 antibiotic susceptibility testing Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 229940121383 antituberculosis agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 102000006635 beta-lactamase Human genes 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960003077 cycloserine Drugs 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 1
- 229960004413 flucytosine Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 238000000760 immunoelectrophoresis Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- AJUXDFHPVZQOGF-UHFFFAOYSA-N n,n-dimethyl-1-naphthylamine Chemical compound C1=CC=C2C(N(C)C)=CC=CC2=C1 AJUXDFHPVZQOGF-UHFFFAOYSA-N 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940026778 other chemotherapeutics in atc Drugs 0.000 description 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229940041153 polymyxins Drugs 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VSQQQLOSPVPRAZ-RRKCRQDMSA-N trifluridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C(F)(F)F)=C1 VSQQQLOSPVPRAZ-RRKCRQDMSA-N 0.000 description 1
- 229960003962 trifluridine Drugs 0.000 description 1
- 239000000814 tuberculostatic agent Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960003636 vidarabine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Materials For Medical Uses (AREA)
- Detergent Compositions (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP84850107A EP0157071B1 (en) | 1984-04-03 | 1984-04-03 | Method and device for producing varying concentration patterns of chemically or biologically active substances |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO851172L true NO851172L (no) | 1985-10-04 |
Family
ID=8193121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO851172A NO851172L (no) | 1984-04-03 | 1985-03-22 | Fremgangsmaate og innretning for fremstilling av varierende konsentrasjonsmoenstre av kjemisk eller biologisk aktive stoff |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0157071B1 (fi) |
| JP (1) | JPS60227696A (fi) |
| AT (1) | ATE45043T1 (fi) |
| AU (1) | AU594016B2 (fi) |
| CA (1) | CA1255215A (fi) |
| DE (1) | DE3479157D1 (fi) |
| DK (1) | DK145785A (fi) |
| FI (1) | FI851249L (fi) |
| NO (1) | NO851172L (fi) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE456246B (sv) * | 1985-08-01 | 1988-09-19 | Biodisk Ab | Anordning for kenslighetsbestemning av mikroorganismer innefattande en icke-poros testremsa med tva olika testsubstanser |
| EP0323605B1 (en) * | 1987-12-21 | 1994-01-26 | Abbott Laboratories | Chromatographic binding assay devices and methods |
| US5639632A (en) * | 1990-03-02 | 1997-06-17 | Ab Biodisk | Method and device for studying and quantifying interacting effects of substances on biological cells |
| ES2090117T3 (es) * | 1990-03-02 | 1996-10-16 | Biodisk Ab | Metodo y dispositivo para estudiar y cuantificar los efectos interactivos de sustancias sobre celulas biologicas. |
| SE522297C2 (sv) | 2001-05-17 | 2004-01-27 | Biodisk Ab | Förfarande och anordning för anbringande av tunna föremål samt användning av förpackning för de tunna föremålen |
| JP2005172475A (ja) * | 2003-12-08 | 2005-06-30 | Mitsubishi Rayon Co Ltd | バイオアッセイプレート及びそれを用いたバイオアッセイ方法 |
| US8021883B2 (en) | 2005-05-11 | 2011-09-20 | Chr. Hansen A/S | Antibiotic-sensitive lactic acid bacteria strains |
| GB0526231D0 (en) | 2005-12-22 | 2006-02-01 | Eastman Kodak Co | Dispersant for reducing viscosity of solids |
| US8226936B2 (en) | 2006-11-15 | 2012-07-24 | Chr-Hansen A/S | Tetracycline-sensitive bifidobacteria strains |
| IT1395483B1 (it) * | 2009-09-21 | 2012-09-28 | Liofilchem Srl | Striscia di carta per la determinazione della concentrazione minima inibente (cmi) di molecole antibiotiche. |
| US20130244316A1 (en) * | 2009-09-21 | 2013-09-19 | Liofilchem S.R.L. | Paper strip for determining minimum inhibitory concentrations of antibiotics |
| TR201706407A2 (tr) * | 2017-05-02 | 2017-09-21 | Ali̇ Kuleoğlu Enver | Mi̇ni̇mal i̇nhi̇bi̇syon konsantrasyonu (mik) beli̇rleme testi̇ şeri̇di̇ |
| WO2019012321A1 (en) * | 2017-07-12 | 2019-01-17 | Gupte Dr Shrikant Vinayak | TEST DEVICE FOR DETERMINING MINIMUM INHIBITOR CONCENTRATION AND ANTIMICROBIAL RESISTANCE IN PATHOGENIC / NON-PATHOGENIC ORGANISMS |
| CN110016494A (zh) * | 2019-04-24 | 2019-07-16 | 张敏 | 一种嗜血杆菌体外药敏试验检测条 |
| WO2024013652A1 (en) | 2022-07-11 | 2024-01-18 | Associação Almascience - Investigação E Desenvolvimento Em Celulose Para Aplicações Inteligentes E Sustentáveis | Cellulose-based microbiological culture device |
| PL442949A1 (pl) * | 2022-11-25 | 2024-05-27 | Biomaxima Spółka Akcyjna | Pasek testowy do wykrywania minimalnego stężenia hamującego (MIC) |
| PL442950A1 (pl) * | 2022-11-25 | 2024-05-27 | Biomaxima Spółka Akcyjna | Pasek testowy do wykrywania minimalnego stężenia hamującego (MIC) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3510263A (en) * | 1968-01-05 | 1970-05-05 | Hach Chemical Co | Test papers,methods for carrying out chemical analyses and methods for making the test papers |
| US3932223A (en) * | 1973-10-12 | 1976-01-13 | Louis Bucalo | Culturing medium |
| SE403382B (sv) * | 1974-03-12 | 1978-08-14 | Orion Yhtyme Oy Orion Diagnost | Sett vid undersokning av effekten av ett biologiskt aktivt emne pa tillvexten av mikroorganismer som odlas pa ett fast eller gelformigt odlingsmedium |
| AU547596B2 (en) * | 1980-12-19 | 1985-10-24 | Minnesota Mining And Manufacturing Company | Test method and article for estimating the concentration of free acid in liquid |
-
1984
- 1984-04-03 AT AT84850107T patent/ATE45043T1/de not_active IP Right Cessation
- 1984-04-03 DE DE8484850107T patent/DE3479157D1/de not_active Expired
- 1984-04-03 EP EP84850107A patent/EP0157071B1/en not_active Expired
-
1985
- 1985-03-22 NO NO851172A patent/NO851172L/no unknown
- 1985-03-28 FI FI851249A patent/FI851249L/fi not_active Application Discontinuation
- 1985-04-01 DK DK145785A patent/DK145785A/da not_active Application Discontinuation
- 1985-04-02 JP JP60070754A patent/JPS60227696A/ja active Granted
- 1985-04-02 CA CA000478154A patent/CA1255215A/en not_active Expired
- 1985-05-01 AU AU41876/85A patent/AU594016B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60227696A (ja) | 1985-11-12 |
| JPH0564735B2 (fi) | 1993-09-16 |
| DE3479157D1 (en) | 1989-08-31 |
| FI851249L (fi) | 1985-10-04 |
| ATE45043T1 (de) | 1989-08-15 |
| AU4187685A (en) | 1986-11-06 |
| EP0157071B1 (en) | 1989-07-26 |
| DK145785D0 (da) | 1985-04-01 |
| DK145785A (da) | 1985-10-04 |
| FI851249A0 (fi) | 1985-03-28 |
| EP0157071A1 (en) | 1985-10-09 |
| CA1255215A (en) | 1989-06-06 |
| AU594016B2 (en) | 1990-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO851172L (no) | Fremgangsmaate og innretning for fremstilling av varierende konsentrasjonsmoenstre av kjemisk eller biologisk aktive stoff | |
| Ryan | Quantitative determination of soluble cellular proteins by radial diffusion in agar gels containing antibodies | |
| EP1141700B1 (en) | Method and material for selective detection of toxins | |
| US5780308A (en) | Calibration reagents for semiquanitative binding assays and devices | |
| US5200321A (en) | Microassay on a card | |
| US5028529A (en) | Method and device for producing varying concentration patterns of chemically or biologically active substances | |
| AU756412B2 (en) | Device and methods for determination of analyte in a solution | |
| US10577638B2 (en) | Systems, devices, and methods for microbial detection and identification, and antimicrobial susceptibility testing | |
| Yulaev et al. | Development of a potentiometric immunosensor for herbicide simazine and its application for food testing | |
| EP0093116B1 (en) | Method of quantitatively assaying microorganisms or substances affecting the growth thereof | |
| EP0462376A2 (en) | Conjugate recovery binding assays | |
| KR20010024457A (ko) | 액체 유제품내의 분석물질을 결정하기 위한 검정 장치 | |
| US4753890A (en) | Analytical element and method for determination of magnesium ions | |
| US4381343A (en) | Determination of antibacterial agents | |
| US8685639B2 (en) | Diagnosis and prognosis of wound infection by measurement of a phospholipase A2 in wound fluid | |
| EP0243066A2 (en) | Element and method for the determination of creatinine or creatine | |
| KR20140034004A (ko) | 아플라톡신 ｂ1 검출용 표지물질 및 이를 포함한 아플라톡신 ｂ1 검출용 키트 | |
| US6509166B1 (en) | Detection and quantification of one or more target analytes in a sample using spatially localized analyte reproduction | |
| Piletskaya et al. | Thylakoid membranes-based test-system for detecting of trace quantities of the photosynthesis-inhibiting herbicides in drinking water | |
| US5063151A (en) | Immunoassay method and kit | |
| SE427389B (sv) | Indikator innefattande en berare och ett reaktionssystem | |
| Magnaghi et al. | The colorful world of sulfonephthaleins: Current applications in analytical chemistry for “old but gold” molecules | |
| EP0239222A1 (en) | Analytical element containing photosensitive compound and filter layer and method of use | |
| US11060053B2 (en) | Method and device for hydrating a hydrating medium by a liquid sample | |
| EP0335866A1 (en) | Test device and method of characterizing biological material |